FMR LLC 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | Cyclerion Therapeutics, Inc. CYCN | FMR LLC | 171,048 7.865% | 40,178 (+30.70%) | Filing |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | Cyclerion Therapeutics, Inc. CYCN | FMR LLC | 130,871 6.042% | -5,115 (-3.76%) | Filing |
| 2021-02-08 10:19 am Purchase | 2021-02-05 | 13G | Cyclerion Therapeutics, Inc. CYCN | FMR LLC | 135,986 8.008% | 9,412 (+7.44%) | Filing |